2026 NPPES data Otology & Neurotology Physician NPI 1417051095 MD
Verify on CMS →

JOHN HOUSE, MD

Otology & Neurotology Physician in LOS ANGELES, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
121
Medicare Part D claims · 84 beneficiaries · Otology & Neurotology Physician avg: 401
Generic prescribing
88%
generic claims · 12% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$200.62
3 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: JOHN HOUSE, MD is a Otology & Neurotology Physician ([object Object]) practicing in LOS ANGELES, California with a Medicare Part D prescribing footprint of 121 claims across 84 beneficiaries — 12% brand-name prescribing . Industry payments of $200.62 across 3 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: JOHN HOUSE, MD filed 121 Medicare Part D claims in 2023 across LOS ANGELES, California. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

JOHN HOUSE, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

JOHN HOUSE, MD at a glance

Quality data not reported

NPI registry status

Active

Issued 09/12/2006

NPI 1417051095

Primary specialty

Otology & Neurotology Physician

Rare

333 US NPIs in this specialty

Medicare Part D claims

121 70% vs specialty avg

2023 prescription claims

Specialty avg: 401

Specialty distribution in California

How Otology & Neurotology Physician compares to other specialties among California providers

California providers

Otology & Neurotology Physician share within California

1. Otology & Neurotology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Otology & Neurotology Physician share within California

Specialty board-certification context

Estimated specialty board-certified rate — Otology & Neurotology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Otology & Neurotology Physician ABMS/AOA estimate

Est. board-certified rate (Otology & Neurotology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Otology & Neurotology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

JOHN HOUSE, MD is a Otology & Neurotology Physician provider practicing in LOS ANGELES, California, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1417051095. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

JOHN HOUSE, MD appears in the CMS NPPES registry as a Otology & Neurotology Physician provider holding MD credentials at 2100 W 3RD ST, LOS ANGELES, CA, 90057, with a listed phone of (213) 483-9930. NPI 1417051095 was issued on 09/12/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what HOUSE most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 121 prescription claims written by this provider, covering 84 Medicare beneficiaries and totaling roughly $5K in drug spend, split 12% brand-name and 88% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Otology & Neurotology Physician is a narrow specialty nationwide, with 333 enrolled providers across 46 states and an average of 401 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

2100 W 3RD ST
LOS ANGELES, CA 90057

Provider Details

NPI 1417051095
Specialty Otology & Neurotology Physician
Credentials MD
Gender Male
NPI Issued 09/12/2006

Hospital and facility affiliations

Facilities where JOHN HOUSE, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

PIH HEALTH PHYSICIANS
LOS ANGELES, CA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for JOHN HOUSE, MD. Source: openpaymentsdata.cms.gov.

Total received

$201

Largest payer

Baxter Healthcare

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to JOHN HOUSE, MD. To verify JOHN HOUSE, MD's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

JOHN HOUSE, MD — brand share 12.0%
Specialty average (est.)

12% brand-name claims vs 88% generic, on 121 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

121
Total Claims
$5K
Total Drug Cost
84
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
153
Total Day Supply
3,273
Brand vs Generic
12% brand / 88% generic
Brand Drug Cost
$1K
Generic Drug Cost
$4K

Patient Demographics

Average Patient Age
73.7 years
Avg HCC Risk Score
1.09
Gender Split
52% female / 48% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Neomycin-Polymyxin-Hc
Neomycin/Polymyxin B/Hydrocort
26
Fluocinolone Acetonide Oil
20
Gabapentin
13

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Otology & Neurotology Physician Overview

How JOHN HOUSE, MD fits within the Otology & Neurotology Physician landscape nationally.

333
Otology & Neurotology Physician Providers in US
46
States with Otology & Neurotology Physician
401
Avg Claims per Provider

JOHN HOUSE, MD's 121 claims are below the specialty average of 401.

Nearby Otology & Neurotology Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as HOUSE.

Compare Otology & Neurotology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is JOHN HOUSE, MD's specialty?
JOHN HOUSE, MD specializes in Otology & Neurotology Physician and practices in LOS ANGELES, California. Credentials: MD.
How much does JOHN HOUSE, MD prescribe under Medicare Part D?
In 2023, JOHN HOUSE, MD wrote 121 Medicare Part D claims totaling $5K in drug costs for 84 beneficiaries.
Where is JOHN HOUSE, MD located?
JOHN HOUSE, MD is located at 2100 W 3RD ST, LOS ANGELES, CA, 90057. Phone: (213) 483-9930.
What is JOHN HOUSE, MD's NPI number?
JOHN HOUSE, MD's National Provider Identifier (NPI) is 1417051095, issued on 09/12/2006.
Does JOHN HOUSE, MD prescribe more brand-name or generic drugs?
JOHN HOUSE, MD's prescribing is 12% brand-name and 88% generic drugs by claim count, with $1K in brand drug costs.
How many Otology & Neurotology Physician providers are there in the US?
There are 333 Otology & Neurotology Physician providers across 46 states in the US. The average Otology & Neurotology Physician provider writes 401 Medicare Part D claims per year.
What drugs does JOHN HOUSE, MD prescribe most often?
Based on 2023 Medicare Part D data, JOHN HOUSE, MD's most frequently prescribed drugs include Neomycin-Polymyxin-Hc, Fluocinolone Acetonide Oil, Gabapentin. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does JOHN HOUSE, MD accept Medicare?
JOHN HOUSE, MD appears in CMS Medicare data with 121 Part D claims and 84 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify JOHN HOUSE, MD's credentials?
JOHN HOUSE, MD's NPI is 1417051095 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology